Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pegylated liposomal doxorubicin in ovarian cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
15,695 | Dovepress* | 15,695+ | 2,691 | 18,386 | |
Totals | 15,695 | 2,691 | 18,386 | ||
*Since 10 August 2009 +Since July 2016 |
View citations on Google Scholar